TRI- Immunophasic Therapy: A Future Landscape

Abstract

The chronic, multifactorial inflammatory disease known as periodontitis is linked to dysbiotic plaque biofilms and is defined by the gradual breakdown of the structure that supports teeth. Its main characteristics are gingival bleeding, periodontal pocketing, radiographically measured alveolar bone loss, and clinical attachment loss (CAL), which indicate a decrease of periodontal tissue support. Owing to its high prevalence, periodontitis is a major public health concern since it can lead to tooth loss and impairment, negatively affect one's look and ability to chew food, exacerbate social inequality, and diminish one's quality of life. Improvements have been made in the diagnosis and treatment of periodontal infections using a variety of contemporary methods that are currently accessible.Controlling the etiological causes and bacteria, reducing inflammation, and replenishing the lost alveolar support are the main goals of periodontal therapy. The main components of periodontal treatment is the surgical and non-surgical therapy. Dissatisfaction with the conventional therapy for protecting oral microbiota and replacing lost alveolar bone support may prompt medical professionals and researchers to investigate the novel and cutting-edge Bone One Session Treatment (BOST). It is an aerobic therapy that supports the alveolar bone and eradicates periodontal disease in the deepest pocket without requiring an intrusive operation. This review paper provides a novel approach, emphasis, and assessment of the important pathway for treating periodontal disease using the Bone One Session Treatment.